Protagonist Therapeutics, Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Newark, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Protagonist Therapeutics, Inc has filed 682 SEC EDGAR filings since 28 Sep 2006

SEC filing history

Showing 301-325 of 681 matching filings.

Per page
25
Current page
13
4

OWNERSHIP DOCUMENT

Filing date
19 Apr 2022
Reporting date
18 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
19 Apr 2022
Reporting date
18 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Apr 2022
Reporting date
14 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37852

DEFA14A

Filing date
13 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37852

DEF 14A

Filing date
13 Apr 2022
Reporting date
26 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-263097

FORM S-8

Filing date
28 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Feb 2022
Reporting date
15 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Feb 2022
Reporting date
15 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Feb 2022
Reporting date
15 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Feb 2022
Reporting date
15 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

SCHEDULE 13G/A, AMENDMENT #1

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

CONSONANCE CAPITAL MANAGEMENT LP

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

PROTAGONIST THERAPEUTICS, INC

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

AMENDMENT NO. 5 TO THE SCHEDULE 13G

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89601

AMENDMENT #4

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .